Viby-Mogensen J, Ostergaard D, Donati F, Fisher D, Hunter J, Kampmann J P, Kopman A, Proost J H, Rasmussen S N, Skovgaard L T, Varin F, Wright P M
Department of Anaesthesia and Intensive Care, Copenhagen University Hospital, Rigshospitalet, Denmark.
Acta Anaesthesiol Scand. 2000 Nov;44(10):1169-90. doi: 10.1034/j.1399-6576.2000.441002.x.
In September 1997, an international consensus conference on standardization of studies of neuromuscular blocking agents was held in Copenhagen, Denmark. Based on the conference, a set of guidelines for good clinical research practice (GCRP) in pharmacokinetic studies of neuromuscular blocking agents is presented. Guidelines include: design of the study; relevant patient groups to investigate; test drug administration, sampling and analysis; pharmacokinetic analysis; pharmacokinetic/pharmacodynamic modeling; population pharmacokinetics; statistics; and presentation of pharmacokinetic data. The guidelines are intended to aid those working in this research area; it is hoped that they will assist researchers, editors of scientific papers, and pharmaceutical companies in improving the quality of pharmacokinetic studies.
1997年9月,关于神经肌肉阻滞剂研究标准化的国际共识会议在丹麦哥本哈根举行。基于此次会议,提出了一套神经肌肉阻滞剂药代动力学研究的良好临床研究实践(GCRP)指南。指南包括:研究设计;要调查的相关患者群体;试验药物的给药、采样和分析;药代动力学分析;药代动力学/药效学建模;群体药代动力学;统计学;以及药代动力学数据的呈现。这些指南旨在帮助该研究领域的工作人员;希望它们能协助研究人员、科学论文编辑和制药公司提高药代动力学研究的质量。